Trial intelligence / Profile preview

Depo-Medrol Injection for Dorsal Scapular Nerve Syndrome

NCT04693312Phase 3Completed

Sponsor
Assiut University
Start
Jan 2020
Primary completion
Mar 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in Dorsal Scapular Neuropathy (DSN), sponsored by Assiut University. Started Jan 2020; status: completed.

02

Drugs

methylprednisolone
03

Conditions

Dorsal Scapular Neuropathy (DSN)

Beyond the preview

Go deeper on NCT04693312.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04693312.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call